Literature DB >> 14968346

[Diabetic foot syndrome].

Hubert Stiegler1.   

Abstract

UNLABELLED: PATHOGENETIC FACTORS: The decisive factors for the etiology of the diabetic foot syndrome (DFS) are diabetic neuropathy, macroangiopathy and the combination of neuropathy with macroangiopathy. If ischemia prevails, macroangiopathy decisively deteriorates the prognosis and leads, together with local infection, to amputation in almost all cases of DFS. Triggering factors are exogenous trauma by tight shoes, foreign bodies and insufficient foot care combined with a foot deformity, which develops in the context of osteoarthropathy. Pathogenetic factors include the increased collagen deposition and network by advanced glycosylation endproducts, the loss of adipose tissue and the occurrence of edema, which destroy the compensating balance between preventive and damaging factors. THERAPY: Regular routine inspections by the physician and the patient for hyperkeratosis, fungal infection, skin lesions, control of footwear and foot deformities are as indispensable as the examination of the neurologic and angiologic status. Treatment requires the know-how of a specialized center in collaboration of different medical disciplines, e. g., the diabetologist, the angiologist, the orthopedic and vascular surgeon, the interventional radiologist and assistance by the podiatrist, the orthopedic technician and expert diabetic counseling. Whereas the neuropathic lesion almost always heals under local therapy and pressure release, ischemic lesions demand revascularization. A superimposed infection calls for microbial and resistance testing, since up to six different agents including anaerobic bacteria can be found. This situation needs systemic antibiotic therapy and local treatment. PROPHYLAXIS: The amputation rate can be considerably reduced by these measures. Even more important is structured teaching of the patient, which can reduce amputation by 60-70%, which underlines the importance of prophylaxis in DFS. Teaching to the patient must comprise daily inspection of the feet, correct hygiene of the feet and adequate footwear.

Entities:  

Mesh:

Year:  2004        PMID: 14968346     DOI: 10.1007/s00059-004-2534-z

Source DB:  PubMed          Journal:  Herz        ISSN: 0340-9937            Impact factor:   1.443


  7 in total

1.  Comparison of five systems of classification of diabetic foot ulcers and predictive factors for amputation.

Authors:  Byung-Joon Jeon; Hwan Jun Choi; Jin Seok Kang; Min Sung Tak; Eun Soo Park
Journal:  Int Wound J       Date:  2016-10-10       Impact factor: 3.315

Review 2.  [Chronic relapsing compartment syndrome].

Authors:  H Stiegler; R Brandl; C Krettek
Journal:  Unfallchirurg       Date:  2009-04       Impact factor: 1.000

Review 3.  [The diabetic foot].

Authors:  A Zimmermann; C Reeps; F Härtl; S Ockert; H-H Eckstein
Journal:  Chirurg       Date:  2009-05       Impact factor: 0.955

4.  Risk factors associated with amputation-free survival in patient with diabetic foot ulcers.

Authors:  Sung Hun Won; Chin Youb Chung; Moon Seok Park; Taeseung Lee; Ki Hyuk Sung; Seung Yeol Lee; Tae Gyun Kim; Kyoung Min Lee
Journal:  Yonsei Med J       Date:  2014-09       Impact factor: 2.759

Review 5.  [The vascular surgeon's role in interdisciplinary treatment of diabetic foot syndrome].

Authors:  G Rümenapf; S Dittler; S Morbach; K Amendt; A Radu
Journal:  Chirurg       Date:  2008-06       Impact factor: 0.920

6.  Proportion of lower limb fungal foot infections in patients with type 2 diabetes at a tertiary care hospital in Sri Lanka.

Authors:  T M Wijesuriya; M M Weerasekera; J Kottahachchi; K N P Ranasinghe; M S S Dissanayake; S Prathapan; T D C P Gunasekara; A Nagahawatte; L D Guruge; U Bulugahapitiya; S S N Fernando
Journal:  Indian J Endocrinol Metab       Date:  2014-01

Review 7.  Prevalence and Risk Factors of Lower Limb Amputation in Patients with End-Stage Renal Failure on Dialysis: A Systematic Review.

Authors:  Rajit A Gilhotra; Beverly T Rodrigues; Venkat N Vangaveti; Usman H Malabu
Journal:  Int J Nephrol       Date:  2016-07-27
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.